Skip to main content
. 2024 Jun 6;9(4):952–958. doi: 10.1177/23969873241256813

Figure 3.

Figure 3.

Distribution of YKL-40 at each time-point of assessment according to favorable outcome (a) and excellent outcome (b). YKL-40: 40 kDa plasma protein with 3 N-terminal amino acids being Y (tyrosine), K (lysine); EVT: endovascular therapy; favorable outcome: modified Rankin Scale score 0–2 at 3 months; excellent outcome: modified Rankin Scale score 0–1 at 3 months.

p-values for logistic regression model after adjustment on age, admission NIHSS and IVT.